OPK - OPKO Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.24B
Enterprise Value 31.46B
Trailing P/E N/A
Forward P/E 1-8.42
PEG Ratio (5 yr expected) 1-0.40
Price/Sales (ttm)1.35
Price/Book (mrq)0.73
Enterprise Value/Revenue 31.58
Enterprise Value/EBITDA 6-11.60

Trading Information

Stock Price History

Beta (3Y Monthly) 2.10
52-Week Change 3-50.36%
S&P500 52-Week Change 32.99%
52 Week High 34.3000
52 Week Low 31.7300
50-Day Moving Average 31.9463
200-Day Moving Average 32.1705

Share Statistics

Avg Vol (3 month) 33.91M
Avg Vol (10 day) 34.56M
Shares Outstanding 5615.6M
Float 362.62M
% Held by Insiders 141.99%
% Held by Institutions 123.71%
Shares Short (Aug 15, 2019) 491.15M
Short Ratio (Aug 15, 2019) 425.59
Short % of Float (Aug 15, 2019) 425.12%
Short % of Shares Outstanding (Aug 15, 2019) 414.81%
Shares Short (prior month Jul 15, 2019) 490.78M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin -26.54%
Operating Margin (ttm)-24.00%

Management Effectiveness

Return on Assets (ttm)-5.54%
Return on Equity (ttm)-13.88%

Income Statement

Revenue (ttm)920.49M
Revenue Per Share (ttm)1.60
Quarterly Revenue Growth (yoy)-14.20%
Gross Profit (ttm)314.61M
EBITDA -125.61M
Net Income Avi to Common (ttm)-244.29M
Diluted EPS (ttm)-0.4240
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)111.11M
Total Cash Per Share (mrq)0.18
Total Debt (mrq)324.75M
Total Debt/Equity (mrq)19.00
Current Ratio (mrq)1.22
Book Value Per Share (mrq)2.78

Cash Flow Statement

Operating Cash Flow (ttm)-159.16M
Levered Free Cash Flow (ttm)-59.86M